EverSource Wealth Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.07K Sell
283
-157
-36% -$3.42K ﹤0.01% 3033
2026
Q1
$7.64K Buy
440
+184
+72% +$3.48K ﹤0.01% 3064
2025
Q4
$4.82K Sell
256
-41
-14% -$687 ﹤0.01% 3137
2025
Q3
$4.32K Sell
297
-222
-43% -$3.17K ﹤0.01% 3221
2025
Q2
$10.1K Buy
519
+306
+144% +$5.44K ﹤0.01% 2795
2025
Q1
$3.78K Buy
213
+189
+788% +$4.07K ﹤0.01% 2630
2024
Q4
$514 Buy
+24
New +$584 ﹤0.01% 3191
2022
Q2
Sell
-60
Closed -$2K 1732
2022
Q1
$2K Hold
60
﹤0.01% 1497
2021
Q4
$3K Buy
+60
New +$3.13K ﹤0.01% 1399

Other funds holding CDNA

EverSource Wealth Advisors's CDNA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its CareDx (CDNA) stake by 36% in Q2 2026, selling an estimated $3.42K and leaving 283 shares worth $8.07K. The position accounts for ﹤0.01% of the portfolio, ranked #3033.

EverSource Wealth Advisors first reported a position in CDNA in Q4 2021 and has held it in 9 quarters since. The position peaked at $10.1K in Q2 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • EverSource Wealth Advisors held 283 shares of CareDx worth $8.07K as of Q2 2026.
  • EverSource Wealth Advisors sold 157 CareDx shares in Q2 2026, an estimated $3.42K.
  • CareDx made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3033 holding.
  • EverSource Wealth Advisors first reported a position in CareDx in Q4 2021 and has held it in 9 quarters since.
  • EverSource Wealth Advisors's CareDx position peaked at $10.1K in Q2 2025.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.